NVCT
Nuvectis Pharma Inc
20.20$
-6.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | +0.0% | +206.5% | -6.0% | -3.0% | +70.4% | |
| – | +0.0% | +249.8% | -6.0% | -3.0% | +70.4% | |
| – | +0.0% | +248.2% | -4.3% | -3.1% | +70.7% | |
| – | +0.0% | +248.2% | -4.3% | -3.1% | +70.7% | |
| – | +176,550.0% | -65.0% | +12.9% | +27.3% | +49.5% | |
| – | +24,090.0% | +155.7% | +12.9% | +27.3% | +49.5% | |
| – | +10,480.0% | +175.0% | -4.8% | -9.9% | +151.2% | |
| – | – | – | -14.2% | -20.4% | +89.6% | |
| – | – | – | – | – | – | |
| – | +0.0% | -0.5% | +22.9% | +10.0% | +27.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.